1. Centers for Disease Control and Prevention. Shigellosis: general information. Available at
http://www.cdc.gov/nczved/divisions/dfbmd/diseases/shigellosis/
, Accessed 1/3/2011
2. Kotloff KL, Winickoff JP, Ivanoff B et al (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651–666
3. Dupont HL (2009) Shigella species (bacillary dysentery). In: Principles and practice of infectious diseases, 6th edn. Elsevier Churchill Livingstone, Oxford, p 2655
4. Christopher PR, David KV, John SM, Sankarapandian V (2010) Antibiotic therapy for shigella dysentery. Cochrane Database Syst Rev CD006784
5. Schneider E, Whitmore S, Glenn MK, For the Division of HIV/AIDS prevention National Center for HIV/AIDS, viral hepatitis, STD, and TB Prevention within the CDC et al (2008) Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. MMWR 57:1–8